Interferon-inducible chemokines reflect severity and progression in sarcoidosis

Respiratory Research

Table 1 Cross-sectional cohort characteristics

	Control	Sarcoidosis	P-Value
	N = 46 (%)	N = 36 (%)
Female	28 (61%)	23 (64%)	0.82
Age (y)^*	42.15 ± 12.96	52.06 ± 11.57	<0.01
Race
African-American	5 (11%)	2 (5%)	0.46
White	33 (72%)	33 (92%)	0.02
Other	8 (17%)	1 (3%)	0.50
Ethnicity
Hispanic	6 (13%)	2 (5%)	0.46
Smoking Status
Ever	11 (24%)	14 (39%)	0.16
Current	4 (8.7%)	1 (3%)	0.38
Cardiac/ocular/CNS	n/a	1/9/7
Pulmonary Function			Range
FEV1 (%)^*		93.9 ± 17.5	47-133
FVC (%)^*		100.0 ± 13.8	63-129
FEV1/FVC (%)^*		72.9 ± 8.4	56.2-94.8
TLC (%)^* N = 25		99.9 ± 15.0	62-124
DLCO (%)^* N = 27		87.77 ± 15.7	45-120
Immunosuppression	None	No immunosuppression at time of or within 3 months of blood draw

ISSN: 1465-993X